

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inf...
Q2 2026
Aug 13, 2026
Q1 2026
May 14, 2026
FY 2025
Mar 10, 2026
Q4 2025
Mar 10, 2026
Q3 2025
Nov 12, 2025